← Leaderboards
Pamela L Paris
University Of California, San Francisco
$2,074,035
Attributed
$2,276,135
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $404.2K · FY2009–23$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,276,135 · 3
By mechanism
R01$1,871,934 · 2
R43$404,201 · 1
Top collaborators
- Randall Davis1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Susan Halabi$7,630,539
- Martin Edwin Gleave$1,721,828
- Daniel B Vigneron$43,424,992
- Ralph Eugene Hurd$2,412,854
- Craig Franklin$17,692,971
Others in their field
Top investigators on “Laboratories”
- David Heimbrook · Leidos Biomedical Research, Inc.$943,075,715
- Lawrence Corey · Fred Hutchinson Cancer Center$747,603,944
- Jeffrey P Krischer · University Of South Florida$627,303,958
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$553,634,937
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$463,311,620
Research focus
LaboratoriesMalignant Neoplasm Of ProstateTumorValidationNeoplasm MetastasisGenomicsParaffin EmbeddingTissuesDiagnosisGleason Grade For Prostate CancerRecurrenceProstate-Specific AntigenCustomMalignant NeoplasmsLymph NodesBaseMaleMetastatic Prostate CancerHigh RiskBlindedDesignGoldGenotypeGenetic
Grant awards (7)
Genomic marker to distinguish aggressive and indolent prostate cancer$404,201
R43 · FY2023 · CA
External validation of GEMCaP, a prognostic DNA biomarker set for CaP recurrence$334,728
R01 · FY2015 · CA · contact PI
External validation of GEMCaP, a prognostic DNA biomarker set for CaP recurrence$310,970
R01 · FY2014 · CA · contact PI
External validation of GEMCaP, a prognostic DNA biomarker set for CaP recurrence$301,352
R01 · FY2013 · CA · contact PI
External validation of GEMCaP, a prognostic DNA biomarker set for CaP recurrence$320,588
R01 · FY2012 · CA · contact PI
External validation of GEMCaP, a prognostic DNA biomarker set for CaP recurrence$320,588
R01 · FY2011 · CA · contact PI
CaP Metastasis Biomarkers: Validation/Genomics/Biology$283,708
R01 · FY2009 · CA · contact PI